- Home
- ROIV vs GPK Comparison
ROIV vs GPK Comparison
Compare ROIV & GPK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ROIV
- GPK
- Stock Information
- Founded
- ROIV 2014
- GPK 2007
- Country
- ROIV United Kingdom
- GPK United States
- Employees
- ROIV N/A
- GPK N/A
- Industry
- ROIV Biotechnology: Pharmaceutical Preparations
- GPK Containers/Packaging
- Sector
- ROIV Health Care
- GPK Consumer Discretionary
- Exchange
- ROIV Nasdaq
- GPK Nasdaq
- Market Cap
- ROIV 8.4B
- GPK 7.4B
- IPO Year
- ROIV N/A
- GPK 1992
- Fundamental
- Price
- ROIV $10.79
- GPK $23.55
- Analyst Decision
- ROIV Buy
- GPK Buy
- Analyst Count
- ROIV 4
- GPK 7
- Target Price
- ROIV $17.50
- GPK $29.17
- AVG Volume (30 Days)
- ROIV 5.9M
- GPK 3.6M
- Earning Date
- ROIV 05-29-2025
- GPK 05-01-2025
- Dividend Yield
- ROIV N/A
- GPK 1.87%
- EPS Growth
- ROIV N/A
- GPK N/A
- EPS
- ROIV N/A
- GPK 2.05
- Revenue
- ROIV $122,585,000.00
- GPK $8,668,000,000.00
- Revenue This Year
- ROIV N/A
- GPK N/A
- Revenue Next Year
- ROIV N/A
- GPK $2.60
- P/E Ratio
- ROIV N/A
- GPK $11.49
- Revenue Growth
- ROIV 140.04
- GPK N/A
- 52 Week Low
- ROIV $8.73
- GPK $20.86
- 52 Week High
- ROIV $13.06
- GPK $30.70
- Technical
- Relative Strength Index (RSI)
- ROIV 50.06
- GPK 48.10
- Support Level
- ROIV $10.58
- GPK $22.77
- Resistance Level
- ROIV $11.77
- GPK $23.45
- Average True Range (ATR)
- ROIV 0.34
- GPK 0.66
- MACD
- ROIV -0.07
- GPK 0.13
- Stochastic Oscillator
- ROIV 17.65
- GPK 54.34
About ROIV Roivant Sciences Ltd.
Roivant Sciences Ltd is a commercial-stage biopharmaceutical company dedicated to improving the delivery of healthcare to patients. It also incubates discovery-stage companies and health technology startups complementary to its biopharmaceutical business. Its drug candidate VTAMA (tapinarof) is a treatment of plaque psoriasis in adult patients and is in its commercial stage. The other drug candidates in their different stages of development are; Batoclimab, IMVT-1402, Brepocitinib, Namilumab, and others.
About GPK Graphic Packaging Holding Company
Graphic Packaging Holding Co is a holding company that manufactures and sells a variety of paper-based consumer packaging products through its subsidiaries. The company's reportable segments are; Paperboard Manufacturing, Americas Paperboard Packaging, and Europe Paperboard Packaging. The majority of the revenue is generated from its Americas Paperboard Packaging segment which includes paperboard packaging sold predominantly to consumer packaged goods (CPG) companies and cups, lids and food containers sold to foodservice companies and quick-service restaurants (QSR) serving the food, beverage, and consumer product markets in the Americas. Geographically, the company generates revenue from the Americas, Europe and Asia Pacific regions.